We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cardiovascular Information System

By HospiMedica staff writers
Posted on 20 Sep 2006
A new release of an integrated cardiovascular information system now integrates exam results from all major cardiology subspecialties--interventional cardiology, cardiovascular ultrasound, electrocardiogram (ECG), nuclear cardiology, cardiac computed tomography (CT), cardiac magnetic resonance imaging (MRI), and electrophysiology (EP). More...


Called the Xcelera R2.1, the system expands into nuclear cardiology domain with new modalities, integrated workflow, and patient-centric work-space design. The system was developed by Philips Medical Systems (Best, The Netherlands), and is used for documentation, viewing, quantification and reporting tasks, and provides clinicians with access to relevant images and information on patients across the hospital from a single workspace.

"Integration is among the most critical necessities facing the cardiovascular world today,” said Oran Muduroglu, chief executive officer, Healthcare Informatics, Philips Medical Systems. "With this new release of Xcelera, we've streamlined workflow by providing instant access to all relevant images and information--across all cardiovascular modalities--at one location.”

In addition to managing examination results in a patient centric-manner, the new release of Xcelera also brings a host of new or enhanced clinical and reporting tools for two-dimensional (2D) and 3D echocardiography, cardiovascular x-ray, nuclear cardiology (powered by AutoQuant), 2D and 3D cardiac CT and MR, as well as for managing EP recording and mapping information. The new design of results management and availability of new and enhanced clinical tools enables cardiac professionals to more effectively diagnose a patient's condition and subsequently make more informed decisions about the method of treatment.

Xcelera R2.1 is pending regulatory clearance in the United States but currently available outside North America.



Related Links:
Philips Medical Systems

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.